In March 2025, the company declared new options for a immediate-to-customer presenting of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which might cost customers $499 per 30 days for entry to the drug, less than fifty percent the price of the drug by means of other pharmaceutical distribution networks.[